Institute of Genetics and Cancer

Innovation and Entrepreneurship Award for University of Edinburgh and Nuvectis

University of Edinburgh and Nuvectis Pharma win Innovation and Entrepreneurship Award: April 2024

Innovation and Entrepreneurship Awards 2024

Congratulations to Edinburgh Cancer Researchers Neil Carragher, Asier Unciti-Broceta, Margaret Frame, Val Brunton and Stefan Symeonides, Maria Lopalco from Edinburgh Innovations and our partners at Nuvectis Pharma for being winners at the Cancer Research Horizons Innovation and Entrepreneurship Awards. Cancer Research Horizons is the innovation engine of the Cancer Research UK, world's largest charitable funder of cancer research, and its Innovation and Entrepreneurship Awards are designed to empower innovation and recognise trailblazers in oncology.

The team were successful in the Further, Faster, Together (Industry-Academia collaboration) category which celebrates the promotion of innovation in oncology through the working together of industry and academia, including but not limited to partnerships, licenses and knowledge exchange. The award recognises outstanding examples of teamwork with clear evidence of knowledge transfer between the different sectors and organisations, and demonstrates how value and impact is maximised through working in partnership and collaboration.

The University of Edinburgh and Nuvectis Pharma have been distinguished for their collaborative work on NXP900 - a novel first-in-class drug with a new mechanism of action, targeting SRC and YES1 kinases. The drug was discovered by the Edinburgh Cancer Researchers at the Institute of Genetic and Cancer. They have partnered with Nuvectis Pharma to speed up translation of their discoveries for patient benefit and clinical trials are now underway in patients with advanced solid tumours.

A picture of the wining team at the award ceremony.
Professors Neil Carragher (left) and Asier Unciti-Broceta (third left) with Enrique Poradosu CSO of Nuvectis Pharma (second left) accepting the Further, Faster, Together (Industry-Academia collaboration) award on behalf of the University of Edinburgh and Nuvectis team at the at the 2024 Cancer Research Horizons Innovation and Entrepreneurship Award ceremony.

Related Links

Innovation and Entrepreneurship Awards 2024: https://www.cancerresearchhorizons.com/innovation-entrepreneurship-awards-2024

Related Stories